Access Statistics for Christopher James Sampson

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Framework for Value-aligned Pricing of Combination Therapies 0 0 3 6 0 1 9 16
Barriers to Uptake of Minimal Access Surgery in the United Kingdom 0 0 0 2 1 3 13 23
Cost implications of treatment non-completion in a forensic personality disorder service 0 0 0 15 0 8 17 60
Drop Dead: Is Anchoring at ‘Dead’ a Theoretical Requirement in Health State Valuation? 0 0 0 9 0 5 12 39
Happy and healthy: a joint model of health and life satisfaction 0 0 0 87 0 6 15 301
How Should We Measure Quality of Life Impact in Rare Disease? Recent Learnings in Spinal Muscular Atrophy 0 0 1 29 0 1 18 108
How is Quality of Life Measured for Health Technology Assessments? 0 0 1 16 0 9 22 61
R&D, Competition and Diffusion of Innovation in the EU: The Case of Hepatitis C 0 0 0 1 0 4 10 15
The Case for Expanding Uptake of Next-Generation Sequencing for Lung Cancer in Europe 0 0 4 7 0 4 14 25
The Impact of New Medicines in the NHS: 70 Years of Innovation 0 0 0 1 0 0 6 12
The impact of inflation on incremental costs in HTA 8 8 8 8 13 13 13 13
The relationship between individual risk and cost-effectiveness in screening interventions 0 0 0 43 1 4 11 302
The value of cell and gene therapies to the UK economy 0 0 0 0 3 3 3 3
Total Working Papers 8 8 17 224 18 61 163 978
4 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Do patients registered with CAM-trained GPs really use fewer health care resources and live longer? A response to Kooreman and Baars. Eur J Health Econ (2012). 13:469–776 0 0 0 3 0 2 17 96
Health Opportunity Costs and Expert Elicitation: A Comment on Soares et al 0 0 0 1 1 3 10 16
Is anchoring at ‘dead’ a theoretical requirement for health state valuation? 0 0 0 1 1 5 13 19
Marginal cost per QALY estimates: What are they good for? 0 0 2 11 0 2 24 61
Model Registration: A Call to Action 0 0 0 4 0 1 8 69
NICE and the EQ-5D-5L: Ten Years Trouble 0 0 1 4 0 2 7 25
Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy 0 0 18 28 0 5 76 150
Transparency in Decision Modelling: What, Why, Who and How? 0 0 0 4 1 3 16 68
Total Journal Articles 0 0 21 56 3 23 171 504


Statistics updated 2026-07-10